Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Influenza

  Free Subscription


10.08.2026

1 Ann Intern Med
2 Antimicrob Agents Chemother
2 Antiviral Res
2 BMC Pediatr
2 J Immunol
8 J Infect Dis
2 PLoS One
2 Proc Natl Acad Sci U S A
1 Vaccine


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. CHEN V, Glatt AE
    In older adults, mRNA-1010 vs. a licensed standard-dose influenza vaccine reduced influenza A- or B-related ILI at a median 181 d.
    Ann Intern Med. 2026 Aug 4. doi: 10.7326/ANNALS-26-02527.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  2. SUN Z, Huang Y, Guo R, Jiang T, et al
    Anti-RSV drug screening and inhibition of RSV infection by lapatinib through the IL-17 pathway.
    Antimicrob Agents Chemother. 2026;70:e0197225.
    PubMed         Abstract available

  3. RODRIGUEZ L, Andreatta K, Chen S, Hu Y, et al
    Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19.
    Antimicrob Agents Chemother. 2026;70:e0191225.
    PubMed         Abstract available


    Antiviral Res

  4. WANG K, Gibbons JS, Bisht N, Reyes AC, et al
    SARS-CoV-2 resistance pathways to EDP-235.
    Antiviral Res. 2026;253:106493.
    PubMed         Abstract available

  5. WU R, Wang H, Yin R, Gemingnuer A, et al
    Nanoparticles in viral pneumonia: diagnosis, therapy, and prevention.
    Antiviral Res. 2026;253:106482.
    PubMed         Abstract available


    BMC Pediatr

  6. CHEN H, Fan Y, Huang Y
    Epidemiological characteristics and seasonal dynamics of six respiratory pathogens in children: a 2-year retrospective cross-sectional study in Chengdu, China.
    BMC Pediatr. 2026;26:718.
    PubMed         Abstract available

  7. AMPOFO K, Heller E, Platt-Koch A, Gesteland P, et al
    Burden of laboratory-confirmed RSV hospitalization in children <5 years-of-age; 2019-2022.
    BMC Pediatr. 2026;26:706.
    PubMed         Abstract available


    J Immunol

  8. ACKLAND J, Barozi V, Penrice-Randal R, Hartley C, et al
    Identifying molecular signatures underpinning treatment responses to novel therapeutics influencing COVID-19 outcomes.
    J Immunol. 2026;215:vkag189.
    PubMed         Abstract available

  9. SILVA JDC, Almeida C, Silva BMS, Bonfim BS, et al
    Elastase and myeloperoxidase participate in neutrophil extracellular trap release stimulated by SARS-CoV-2.
    J Immunol. 2026;215:vkaf313.
    PubMed         Abstract available


    J Infect Dis

  10. SMITH D, Weir IR, Ramirez S, Coelho CH, et al
    Impact of COVID-19 Monoclonal Antibody Therapy on Subsequent Vaccine-elicited SARS-CoV-2 Immune Responses.
    J Infect Dis. 2026 Feb 17:jiag091. doi: 10.1093.
    PubMed         Abstract available

  11. PLATT AP, Callier V, Grazioli A, Hu Z, et al
    Association of Plasma Biomarkers of Immunothrombosis With Death in Patients With Coronavirus Disease 2019 on Extracorporeal Membrane Oxygenation.
    J Infect Dis. 2026;234:e40-e53.
    PubMed         Abstract available

  12. SANGIORGIO G, Chamberlin G, Castagnoli R, Wachter B, et al
    Immune-Based Cytokine Signatures of Prolonged Pandemic-Associated Chilblains.
    J Infect Dis. 2026;234:e29-e33.
    PubMed         Abstract available

  13. JAYAWARDENA I, Dean NE, Witrick B, Litwin AH, et al
    2024-2025 COVID-19 mRNA Vaccine Effectiveness against Severe Disease.
    J Infect Dis. 2026 Mar 2:jiag137. doi: 10.1093.
    PubMed         Abstract available

  14. ROSAS-SALAZAR C, Gebretsadik T, Chappell JD, Peebles RS Jr, et al
    Infant Infection With Respiratory Syncytial Virus Genotypes and Subsequent Childhood Asthma Risk.
    J Infect Dis. 2026;234:e34-e39.
    PubMed         Abstract available

  15. KACHIKIS A, Frivold C, Pike M, Reed JC, et al
    Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination.
    J Infect Dis. 2026 Mar 26:jiag111. doi: 10.1093.
    PubMed         Abstract available

  16. KOBERSSY Z, Daher J, Durieux JC, Atieh O, et al
    Comparison of Immune Activation and Gut Barrier Dysfunction between Long COVID and HIV infection.
    J Infect Dis. 2026 Mar 31:jiag146. doi: 10.1093.
    PubMed         Abstract available

  17. FEYS S, Heylen J, Goncalves SM, Pereira I, et al
    Genetic variation in the long pentraxin PTX3 and Dectin-1 does not predispose to influenza- or COVID-19-associated pulmonary aspergillosis.
    J Infect Dis. 2026 Aug 7:jiag403. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  18. ALSHAMMARI AO, Alshammari HO, Ali H, Himmat B, et al
    A flexible exponential type family for modeling non-monotonic hazard rates with application to mortality analysis: A COVID-19 case study.
    PLoS One. 2026;21:e0331050.
    PubMed         Abstract available

  19. GOURAUD C, Guemouni S, Thoreux P, Ouazana-Vedrines C, et al
    Health-related quality of life among patients with long COVID according to the presence of a diagnosis of functional somatic disorder: A cross-sectional study.
    PLoS One. 2026;21:e0354238.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  20. ZHOU J, Li W, Wang X, Sun J, et al
    A structural and mechanistic atlas of NTD antibody neutralization and immune escape across SARS-CoV-2 prototype and its (sub-)variants.
    Proc Natl Acad Sci U S A. 2026;123:e2535385123.
    PubMed         Abstract available

  21. MULLER L, Sartori F, Dehning J, Eggl MF, et al
    Optimizing infectious disease mitigation under dynamic conditions.
    Proc Natl Acad Sci U S A. 2026;123:e2527395123.
    PubMed         Abstract available


    Vaccine

  22. XU N, Wang L, Zhao C, Shen Y, et al
    Advances in clinical immunogenicity evaluation of influenza vaccines.
    Vaccine. 2026;89:128989.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum